Giant Biogene Holding Co (HKSE:02367) Margin of Safety % (DCF FCF Based): N/A (As of Sep. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02367 Giant Biogene Holding Co Ltd HKSE:02367
85 GF Score
Price HK$24.46
GF Value HK$68.03
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Giant Biogene Holding Co Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Giant Biogene Holding Co's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

HKSE:02367 vs PG, CL, EL: Margin of Safety % (DCF FCF Based) Comparison

For the Household & Personal Products subindustry, Giant Biogene Holding Co's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Giant Biogene Holding Co Margin of Safety % (DCF FCF Based) vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Giant Biogene Holding Co's Margin of Safety % (DCF FCF Based) falls into.


HKSE:02367
85GF Score
Giant Biogene Holding Co Ltd HKSE:02367
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Giant Biogene Holding Co (HKSE:02367) Overvalued in 2026?

Based on GuruFocus' analysis, Giant Biogene Holding Co stock appears to be undervalued. The current stock price of HK$24.46 is trading 64% below its estimated GF Value™ of HK$68.03. GuruFocus considers Giant Biogene Holding Co to be Possible Value Trap.

Key valuation signals for HKSE:02367:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: HK$68.03 vs. price of HK$24.46 (64% below fair value)
  • GF Score™: 85/100 with 4 warning signs

No single metric tells the full story. See the HKSE:02367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Giant Biogene Holding Co Business Description

Address No. 1855, Shanglin Yuan 7th Road, Chang’an District, Shaanxi Province, Xi’an, CHN
Giant Biogene Holding Co Ltd designs, develops, and manufactures professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenoside technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop & manufacture multiple types of recombinant collagen & rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty & health properties such as skin repair, anti-aging, whitening, moisturizing, & immunity improvement, with a broad range of applications in the beauty & health sectors. The group is organised into a single business unit that mainly includes the research, development, manufacture, & sale of bioactive material-based beauty & health products.
85GF Score

Get the complete analysis for HKSE:02367

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$24.46
Price
HK$68.03
GF Value